Close
ACHEMA MIDDLE EAST 2026

Almac Group Extends Personalized Cancer Vaccine Production Facilities

The Almac Group is expanding its Edinburgh Technopole facility to allow scale-up of its personalized cancer vaccine activities. Doubling its footprint in the Fleming...

GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to a Diagnostic Assay for Non-Alcoholic Steatohepatitis

LabCorp, a leading global life sciences company, and GENFIT , a biopharmaceutical company focused on discovering and developing drug candidates and diagnostic solutions targeting...

Canadian companies complete handover of drugs rights

Nuvo Pharmaceuticals has acquired the rights covering more than 20 drugs from fellow Canadian company Aralez Pharmaceuticals. With the deal, announced by Nuvo on Monday,...

Proposed Combination of Mereo BioPharma and OncoMed Pharmaceuticals

British pharmaceutical company Mereo BioPharma Group has announced a proposal to merge with US-based drugmaker OncoMed Pharmaceuticals. The integrated business will feature a portfolio of...

AMAL Therapeutics raises CHF 33.2 Million Series B Round

AMAL Therapeutics SA , a Swiss biotech developing peptide-based therapeutic cancer vaccines, announces that it has completed the second closing of its Series B...

MedPharm Ltd signals growth intentions with appointment of Eugene Ciolfi as President and CEO

MedPharm Ltd is pleased to announce that Eugene Ciolfi has joined as its President and Chief Executive Officer. In conjunction with his hiring, he...

Pharmintech 2019: Big increase in International Participation Expected

The nutritional and biotech sectors, medical devices, personal care products and, more broadly, the entire pharmaceutical industry are the focus of the upcoming edition...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...